Eupraxia Pharmaceuticals Inc. (EPRX) News
Track canonical SquawkNews coverage tagged to EPRX, Eupraxia Pharmaceuticals Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Eupraxia Pharmaceuticals Q2 EPS In Line
Eupraxia Pharmaceuticals reports Q2 EPS of $(0.23), meeting estimates
EARNINGS | Aug 11, 2026, 09:32 PM UTC
L
EPRX Reports Second Quarter 2026 Financial Results
Eupraxia Pharmaceuticals reports second quarter 2026 financial results
EARNINGS | Aug 11, 2026, 09:21 PM UTC
M
EPRX: Oppenheimer Initiates
Oppenheimer initiates coverage on Eupraxia Pharmaceuticals with an Outperform rating and a price target of $17
EQUITY | Jun 26, 2026, 01:12 PM UTC
M
BDC: BUY @ Citi
Citi initiates BDC with a BUY rating, among other top initiations
EQUITY | Jun 26, 2026, 11:17 AM UTC